Neda T, Inukai K, Kurihara S, Ono H, Hosaka T, Nakamoto H, Katayama S, Awata T.Hypoglycemic effects of colestimide on type 2 diabetic patients with obesity.Endocr J. 59(3):239-46, 2012.
2012
Sakai T, Shuto E, Taki T, Imamura H, Kioka M, Nakamoto A, Mizoguchi S, Amano S, Kawano Y, Nakamoto M, Tsutsumi R, Hosaka T.Decreased expression of MHC class II and cathepsin E in dendric cells might contribute to impaired induction of antigen-specific T cell response in NC/Nga mice.J Med Invest. 59(1-2):95-101, 2012.
2012
Tsutsumi R, Tsutsumi YM, Horikawa Y, Takehisa Y, Hosaka T, Harada N, Sakai T, Nakaya YDecline in anthropometric evaluation predicts a poor prognosis in geriatric patients.Asia Pac J Clin Nutr. 21(1):44-51, 2012.
2012
Li Q, Hosaka T, Shikama Y, Bando Y, Kosugi C , Kataoka N, Nakaya Y, Funaki MHeparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway.Endocrinology. 153(1):56-68, 2012.
2011
Lustig Y, Ruas JL, Estall JL, Lo JC, Devarakonda S, Laznik D, Choi JH, Ono H, Olsen JV, Spiegelman BM.Separation of the gluconeogenic and mitochondrial functions ofPGC-1α through S6 kinase.Genes Dev. 25(12):1232-44, 2011.
2011
Yamashiro K, Mori K, Nakata I, Tsuchihashi T, Horie-Inoue K, Nakanishi H, Tsujikawa A, Saito M, Iida T, Yamada R, Matsuda F, Inoue S, Awata T, Yoneya S, Yoshimura N.Association of elastin gene polymorphism to age-related macular degeneration and polypoidal choroidal vasculopathy.Invest Ophthalmol Vis Sci. 52(12):8780-8784, 2011.
2011
Sone H, Tanaka S, Tanaka S,. Iimuro S, Oida ., Yamasaki Y,. Oikawa S, Ishibashi S, Katayama S, Ohashi , Akanuma Y, Yamada .N, Japan Diabetes Complications Study Group.Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS).J Clin Endocrin Metab 96(11):3448-3456, 2011.
2011
Januszewicz A, Ritz E, Viberti G, Mimran A, Rabelink AJ, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL Jr, Haller H.Office and ambulatory pulse pressure-association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).J Hum Hypertens. 25(11):679-85, 2011.
2011
Nakatsu Y, Sakoda H, Kushiyama A, Zhang J, Ono H, Fujishiro M, Kikuchi T, Fukushima T, Yoneda M, Ohno H, Horike N, Kanna M, Tsuchiya Y, Kamata H, Nishimura F, Isobe T, Ogihara T, Katagiri H, Oka Y, Takahashi S, Kurihara H, Uchida T, Asano T.Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis.J Biol Chem. 286(23):20812-22, 2011.
2011
Nakamura K, Kawasaki E, Imagawa A, Awata T, Ikegami H, Uchigata Y, Kobayashi T, Shimada A, Nakanishi K, Makino H, Maruyama T, Hanafusa T; Research Committee on Type 1 Diabetes of the Japan Diabetes Society.Type 1 diabetes and interferon therapy: a nationwide survey in Japan.Diabetes Care. 34(9):2084-2089, 2011.
2011
Nakamoto M, Shuto E, Hosaka T, Sakai T.Dietary deoxynucleic acid induces type 2 T-helper immune response through toll-like receptor 9 in mice.Eur J Nutr. 50(6):421-426, 2011.
2011
Yamashita H, Awata T, Kawasaki E, Ikegami H, Tanaka S, Maruyama T, Shimada A, Nakanishi K, Takahashi K, Kobayashi T, Kawabata Y, Miyashita Y, Kurihara S, Morita-Ohkubo T, Katayama S; Japanese Study Group on Type 1 Diabetes Genetics. Analysis of the HLA and non-HLA susceptibility loci in Japanese type 1 diabetes.Diabetes Metab Res Rev. 27(8):844-848, 2011.
2011
Inoue T, Kozawa E, Okada H, Inukai K, Watanabe S, Kikuta T, Watanabe Y, Takenaka T, Katayama S, Tanaka J, Suzuki H.Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J Am Soc Nephrol. 22(8):1429-1434, 2011.
2011
Hosaka T, Nii Y, Tomotake H, Ito T, Tamanaha A , Yamasaka Y, Sasaga S, Edazawa K, Tsutsumi R, Shuto E, Okahisa N, Iwata S Sakai T.Extracts of common buckwheat bran prevent sucrose digestion.J Nutr Sci Vitaminol. 57(6):441-445, 2011.
2011
Ohno H, Nakatsu Y, Sakoda H, Kushiyama A, Ono H, Fujishiro M, Otani Y, Okubo H, Yoneda M, Fukushima T, Tsuchiya Y, Kamata H, Nishimura F, Kurihara H, Katagiri H, Oka Y, Asano T.4F2hc stabilizes GLUT1 protein and increases glucose transport activity.Am J Physiol Cell Physiol. 300(5):C1047-54, 2011.
2011
Kabasawa S, Mori K, Horie-Inoue K, Gehlbach PL, Inoue S, Awata T, Katayama S, Yoneya S.Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population.Ophthalmology. 118(6):1082-1088, 2011.
2011
Nakano T, Matsui M, Inoue I, Awata T, Katayama S, Murakoshi T.Free immunoglobulin light chain: its biology and implications in diseases.Clinica Chimica Acta. 412(11-12):843-849, 2011
2011
Katayama S, Moriya T, Tanaka S, Tanaka S, Yajima Y, Sone H, Iimuro S, Ohashi Y, Akanuma Y, Yamada N for the Japan Diabetes Complications Study Group.Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS).Diabetologia 54(5):1025-1031, 2011.
2011
Aida K, Nishida Y, Tanaka S, Maruyama T, Shimada A, Awata T, Suzuki M, Shimura H, Takizawa S, Ichijo M, Akiyama D, Furuya F, Kawaguchi A, Kaneshige M, Itakura J, Fujii H, Endo T, Kobayashi T.RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes.Diabetes. 60(3):884-9, 2011.
2011
Haller H, Ito S, Izzo Jr. JL, Januszewicz A, Katayama S, Menne J, Mimran A,. Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G.Prevention of microalbuminuria in type 2 diabetes (ROADMAP Trial).N Engl J Med 364(10):907-917, 2011.
2011
Tabuchi M, Seo M, Inoue T, Ikeda T, Kogure A, Inoue I, Katayama S, Matsunaga T, Hara A, Komoda T.A novel geometrical separation method for lipoproteins using bioformulated-fiber matrix electrophoresis: the size of high-density lipoprotein does not reflect its density.Anal Chem. 83(3):1131-1136, 2011
2011
Ito D, Inukai K, Sumita T, Ono H, Katayama S, Awata T. Regulation of pigment epithelium-derived factor (PEDF), an insulin resistance-inducing adipocytokine, in 3T3-L1 adipocytes. Journal of Diabetes & Metabolism 2(8); 1000151: 2011
2010
Ikeda T, Seo M, Inoue I, Katayama S, Matsunaga T, Hara A, Komoda T, Tabuchi M.Direct and simple fluorescence detection method for oxidized lipoproteins.Anal Chem. 82:1128-1132, 2010
2010
Tsuchihashi T, Mori K, Horie-Inoue K, Gehlbach PL, Kabasawa S, Takita H, Ueyama K, Okazaki Y, Inoue S, Awata T, Katayama S, Yoneya S.Complement Factor Hand High-Temperature Requirement A-1 Genotypes and Treatment Response of Age-related Macular Degeneration.Ophthalmology. 118(1):93-100, 2010
2010
Awata TVascular endothelial growth factor gene polymorphisms in susceptibility to coronary artery disease.Am J Hypert. 23 : 938-939, 2010.
2010
Inoue I, Awata T, Katayama SRetrospective, observation study: Quantitative and qualitative effect of ezetimibe and HMG-CoA reductase inhibitors on LDL-cholesterol: are there disappearance thresholds for small , dense LDL and IDL?.Recent Pat Cardiovasc Drug Discov. 5(2) : 143-152, 2010.
2010
Mori K, Horie-Inoue K, Gehlbach PL, Takita H, Kabasawa S, Kawasaki I, Ohkubo T, Kurihara S, Iizuka H, Miyashita Y, Katayama S, Awata T, Yoneya S, Inoue SPhenotype and genotype characteristics of age-related macular degeneration in a Japanese Popularion.Ophthalmology. 117(5) : 928-938, 2010.
2010
Seiichiro Takahashi, Ikuo Inoue, Yoshihiro Nakajima, Makoto Seo, Takanari Nakano, FangYang, Megumi Kumagai, Tsugikazu Komoda, Takuya Awata, Masaaki Ikeda, and Shigehiro Katayama:A promoter the novel exon of hPPARγ directs the circadian expression of PPARγ.J Atherosc Thromb. 17(1) : 73-83, 2010.
2010
Sone H, Tanaka S, Iimuro S, Tanaka S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Yamashita H, Ito H, Yoshikura Y, Ohashi Y, Akanuma Y, Yamada N, for the Japan Diabetes Complications Study Group:Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicenter randomized controlled trial:（the Japan Diabetes Complications Study). Diabetologia. 53 : 419-428, 2010.
2010
Ritz E, Viberti GC, Ruilope LM, Rabelink AJ, Izzo JL, Katayama S, S Ito, Mimran A, Menne J, Rump LC, Januszewicz, H Haller:Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia. 53 : 49-57, 2010.
2010
Watanabe M, Inukai K, Sumita T, Ikebukuro K, Ito D, Kurihara S, Ono H, Awata T, Katayama S.Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients.Intern Med. 49(17) : 1843-7, 2010.
